2025 Q4 -tulosraportti
35 päivää sitten
‧32 min
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 571 | - | - | ||
| 4 823 | - | - | ||
| 4 000 | - | - | ||
| 180 991 | - | - | ||
| 2 009 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·8 t sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·7 t sittenQuestion: How many price targets have previously been here/simultaneously? I.e. WHAT? can we reasonably expect?·7 t sittenBager Correct - we'll see, so why all the haste today? Imagine if next week you have to sulk again about losing money on bioporto. You've been there before, after all. Just relax and don't anticipate developments when there are no developments.
·10 t sittenI just discovered that Bioporto has created a new tab where they make sure to keep us updated and there they also inform how they view the matter. Their breaking news bar is the blue tab at the top of Bioporto's front page. I just skimmed through it, and everything I have written previously aligns with what they state on the page. If you scroll down you can sign up for a newsletter so you get notified when there is news from KDIGO. https://bioporto.com/kgido-announcement/
·10 t sitten · MuokattuNow, I'm by no means an expert in TA. but there are some tools in here - see "Technical Analysis" above. The 200-day moving average (SMA 200) is currently at 1,125 If it breaks, it can be a buy signal and a sign of a trend reversal. Furthermore, SMA 20 broke above SMA 50 a couple of days ago, which indicates a bullish cross. The price is rising faster than the long-term average, which signals positive momentum.·8 t sitten · MuokattuInteresting if it will be 2024 all over again. Investors' great hope towards yet another "important" milestone and subsequently nothing happens with the revenue and the shares are dumped again.- ·1 päivä sittenLove it :-)
- ·2 päivää sitten · MuokattuIf there are others who also want to stay informed about what is happening with KDIGO and the NGAL test, and don't want to be surprised when the final recommendation comes, I have inserted two links at the bottom. On KDIGO's website, we can keep an eye on whether KDIGO releases official news about the NGAL test. but that will only be after May 11th. If there are any ongoing announcements about how the committee views the topic, or which way it seems to be going, I have inserted a link to the magazine where Poul Palevsky and Marlies Ostermann might choose to speak to their journalists. They are usually the ones who comment. They are not allowed to say exactly what is happening, but they will use the same words CB used. it seems that: -a change is coming -it's time to change the procedure -it seems that the previous measurement method is outdated. In that vein, they indirectly say that one should expect a recommendation to come, and it will be significant. We can expect a new standard to come, and some things will receive a 1st-degree recommendation, but how many areas? and others will receive 2? It could also be that all areas receive a 1st-degree recommendation? ( my opinion is the 1/2 solution) KDIGO's bulletin board about the NGAL test https://kdigo.org/guidelines/acute-kidney-injury/ JASN magazine https://journals.lww.com/JASN/pages/default.aspx·1 päivä sittenWhen it's constructive criticism and one can document it, and it's the post one has in mind, then it's important that it comes out, in my opinion. I have muted several people in here because they have a behavior that we call trolls. They don't even own Bioporto, but have lost money on them at some point, and they apparently imagine that they can make Bioporto go bankrupt by several people working together with undocumented posts (according to themselves). I have an open account, so everyone can see that I have continuously bought up and kept my shares in the portfolio. I do as I write. Normally I always include links, but it's difficult with KDIGO, because there are many articles and statements that I have simplified here. Please fact-check yourself.·1 päivä sittenThat's simply not true. You only want to debate with those who agree with you. Everyone who is critical of your one-sided positive posts is muted immediately, even though the price chart clearly shows and documents that there has never !!! been substance in your hype and excessive optimism. It's fine to be positive, if there's evidence for it. But there isn't. In the many years you've been writing, the price has just fallen and fallen and fallen. And just like BP, Stenocare has also fallen approx 80-90% in the last 5 years, and yet you also fill that debate with emotional positive posts. Again, it's fine to be positive and critical. But when you, over many years, have never written even one genuinely critical post about a stock that has fallen 90%, then you're not debating. Then you're hyping. So I have to agree with progression when he recommends that one really uses their critical sense when reading here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
35 päivää sitten
‧32 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·8 t sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·7 t sittenQuestion: How many price targets have previously been here/simultaneously? I.e. WHAT? can we reasonably expect?·7 t sittenBager Correct - we'll see, so why all the haste today? Imagine if next week you have to sulk again about losing money on bioporto. You've been there before, after all. Just relax and don't anticipate developments when there are no developments.
- ·10 t sittenI just discovered that Bioporto has created a new tab where they make sure to keep us updated and there they also inform how they view the matter. Their breaking news bar is the blue tab at the top of Bioporto's front page. I just skimmed through it, and everything I have written previously aligns with what they state on the page. If you scroll down you can sign up for a newsletter so you get notified when there is news from KDIGO. https://bioporto.com/kgido-announcement/
- ·10 t sitten · MuokattuNow, I'm by no means an expert in TA. but there are some tools in here - see "Technical Analysis" above. The 200-day moving average (SMA 200) is currently at 1,125 If it breaks, it can be a buy signal and a sign of a trend reversal. Furthermore, SMA 20 broke above SMA 50 a couple of days ago, which indicates a bullish cross. The price is rising faster than the long-term average, which signals positive momentum.·8 t sitten · MuokattuInteresting if it will be 2024 all over again. Investors' great hope towards yet another "important" milestone and subsequently nothing happens with the revenue and the shares are dumped again.
- ·1 päivä sittenLove it :-)
- ·2 päivää sitten · MuokattuIf there are others who also want to stay informed about what is happening with KDIGO and the NGAL test, and don't want to be surprised when the final recommendation comes, I have inserted two links at the bottom. On KDIGO's website, we can keep an eye on whether KDIGO releases official news about the NGAL test. but that will only be after May 11th. If there are any ongoing announcements about how the committee views the topic, or which way it seems to be going, I have inserted a link to the magazine where Poul Palevsky and Marlies Ostermann might choose to speak to their journalists. They are usually the ones who comment. They are not allowed to say exactly what is happening, but they will use the same words CB used. it seems that: -a change is coming -it's time to change the procedure -it seems that the previous measurement method is outdated. In that vein, they indirectly say that one should expect a recommendation to come, and it will be significant. We can expect a new standard to come, and some things will receive a 1st-degree recommendation, but how many areas? and others will receive 2? It could also be that all areas receive a 1st-degree recommendation? ( my opinion is the 1/2 solution) KDIGO's bulletin board about the NGAL test https://kdigo.org/guidelines/acute-kidney-injury/ JASN magazine https://journals.lww.com/JASN/pages/default.aspx·1 päivä sittenWhen it's constructive criticism and one can document it, and it's the post one has in mind, then it's important that it comes out, in my opinion. I have muted several people in here because they have a behavior that we call trolls. They don't even own Bioporto, but have lost money on them at some point, and they apparently imagine that they can make Bioporto go bankrupt by several people working together with undocumented posts (according to themselves). I have an open account, so everyone can see that I have continuously bought up and kept my shares in the portfolio. I do as I write. Normally I always include links, but it's difficult with KDIGO, because there are many articles and statements that I have simplified here. Please fact-check yourself.·1 päivä sittenThat's simply not true. You only want to debate with those who agree with you. Everyone who is critical of your one-sided positive posts is muted immediately, even though the price chart clearly shows and documents that there has never !!! been substance in your hype and excessive optimism. It's fine to be positive, if there's evidence for it. But there isn't. In the many years you've been writing, the price has just fallen and fallen and fallen. And just like BP, Stenocare has also fallen approx 80-90% in the last 5 years, and yet you also fill that debate with emotional positive posts. Again, it's fine to be positive and critical. But when you, over many years, have never written even one genuinely critical post about a stock that has fallen 90%, then you're not debating. Then you're hyping. So I have to agree with progression when he recommends that one really uses their critical sense when reading here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 571 | - | - | ||
| 4 823 | - | - | ||
| 4 000 | - | - | ||
| 180 991 | - | - | ||
| 2 009 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
2025 Q4 -tulosraportti
35 päivää sitten
‧32 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·8 t sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·7 t sittenQuestion: How many price targets have previously been here/simultaneously? I.e. WHAT? can we reasonably expect?·7 t sittenBager Correct - we'll see, so why all the haste today? Imagine if next week you have to sulk again about losing money on bioporto. You've been there before, after all. Just relax and don't anticipate developments when there are no developments.
- ·10 t sittenI just discovered that Bioporto has created a new tab where they make sure to keep us updated and there they also inform how they view the matter. Their breaking news bar is the blue tab at the top of Bioporto's front page. I just skimmed through it, and everything I have written previously aligns with what they state on the page. If you scroll down you can sign up for a newsletter so you get notified when there is news from KDIGO. https://bioporto.com/kgido-announcement/
- ·10 t sitten · MuokattuNow, I'm by no means an expert in TA. but there are some tools in here - see "Technical Analysis" above. The 200-day moving average (SMA 200) is currently at 1,125 If it breaks, it can be a buy signal and a sign of a trend reversal. Furthermore, SMA 20 broke above SMA 50 a couple of days ago, which indicates a bullish cross. The price is rising faster than the long-term average, which signals positive momentum.·8 t sitten · MuokattuInteresting if it will be 2024 all over again. Investors' great hope towards yet another "important" milestone and subsequently nothing happens with the revenue and the shares are dumped again.
- ·1 päivä sittenLove it :-)
- ·2 päivää sitten · MuokattuIf there are others who also want to stay informed about what is happening with KDIGO and the NGAL test, and don't want to be surprised when the final recommendation comes, I have inserted two links at the bottom. On KDIGO's website, we can keep an eye on whether KDIGO releases official news about the NGAL test. but that will only be after May 11th. If there are any ongoing announcements about how the committee views the topic, or which way it seems to be going, I have inserted a link to the magazine where Poul Palevsky and Marlies Ostermann might choose to speak to their journalists. They are usually the ones who comment. They are not allowed to say exactly what is happening, but they will use the same words CB used. it seems that: -a change is coming -it's time to change the procedure -it seems that the previous measurement method is outdated. In that vein, they indirectly say that one should expect a recommendation to come, and it will be significant. We can expect a new standard to come, and some things will receive a 1st-degree recommendation, but how many areas? and others will receive 2? It could also be that all areas receive a 1st-degree recommendation? ( my opinion is the 1/2 solution) KDIGO's bulletin board about the NGAL test https://kdigo.org/guidelines/acute-kidney-injury/ JASN magazine https://journals.lww.com/JASN/pages/default.aspx·1 päivä sittenWhen it's constructive criticism and one can document it, and it's the post one has in mind, then it's important that it comes out, in my opinion. I have muted several people in here because they have a behavior that we call trolls. They don't even own Bioporto, but have lost money on them at some point, and they apparently imagine that they can make Bioporto go bankrupt by several people working together with undocumented posts (according to themselves). I have an open account, so everyone can see that I have continuously bought up and kept my shares in the portfolio. I do as I write. Normally I always include links, but it's difficult with KDIGO, because there are many articles and statements that I have simplified here. Please fact-check yourself.·1 päivä sittenThat's simply not true. You only want to debate with those who agree with you. Everyone who is critical of your one-sided positive posts is muted immediately, even though the price chart clearly shows and documents that there has never !!! been substance in your hype and excessive optimism. It's fine to be positive, if there's evidence for it. But there isn't. In the many years you've been writing, the price has just fallen and fallen and fallen. And just like BP, Stenocare has also fallen approx 80-90% in the last 5 years, and yet you also fill that debate with emotional positive posts. Again, it's fine to be positive and critical. But when you, over many years, have never written even one genuinely critical post about a stock that has fallen 90%, then you're not debating. Then you're hyping. So I have to agree with progression when he recommends that one really uses their critical sense when reading here.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 571 | - | - | ||
| 4 823 | - | - | ||
| 4 000 | - | - | ||
| 180 991 | - | - | ||
| 2 009 | - | - |
Välittäjätilasto
Dataa ei löytynyt